Clinical Trial Update: Experimental Studies of the Effects of Caffeine on Glucose Regulation [EARLY_Phase 1]

View source ↗

Summary

This early-phase 1 clinical trial examined how caffeine affects glucose regulation in individuals with type 2 diabetes. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Caffeine (caffeine)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Diabetes Mellitus, Type 2 | EARLY_Phase 1 | Status: COMPLETED